Caption Management’s Medifast MED Stock Holding History

Caption Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,000	Closed	-$7.7M	–	820
2019 Q2	$7.7M	Buy	+60,000	New	+$8.34M	0.39%	64

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Caption Management's MED Position: Q1 2026 in Review

Caption Management sold out of Medifast (MED) in Q1 2026, closing a stake of 4,396 shares — an estimated $46.9K sold.

Caption Management first reported a position in MED in Q4 2023 and held it in 4 quarters. The position peaked at $1.24M in Q4 2023. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Caption Management reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
Caption Management sold 4,396 Medifast shares in Q1 2026, an estimated $46.9K.
Caption Management first reported a position in Medifast in Q4 2023 and held it in 4 quarters.
Caption Management's Medifast position peaked at $1.24M in Q4 2023.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.